EMLA Patch empl 20 pce

7680529800386 CH-52980 N01BB20 01.02.2.

Reimbursement limitations:

EMLA

Pour des enfants jusqu'à 16 ans et des patients dialysés.

EMLA Patch empl 20 pce
EMLA Patch empl 20 pce
EMLA Patch empl 20 pce
1 / 3
google

Details

Product number
5298001
CPT
-
Packaging group
20
Unit
Pflaster
Composition
Tela cum emulsione 1g/9.6 cm², lidocainum 25 mg, prilocainum 25 mg, excipiens ad emulsionem pro 1 g.

Articles (1)

Emla Patch, Pflaster
Pflaster
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/09/2025
Patient information leaflet
Français
15/09/2025
Patient information leaflet
Italien
15/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
19.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Aspen Pharma Schweiz GmbH

6340 Baar

Authorization information

Swissmedic authorization number
52980
Drug name
Emla Patch, wirkstoffhaltiges Pflaster
Galenic form
WIRSP
ATC Code
N01BB20
Authorization status
Z
Dispensation category
B
First authorization
14/11/1995
Authorization expiration date
31/12/9999
IT number
01.02.2.
Domain
Human medicine
Field of application
Anästhesie der Haut

Packaging details

Description (FR)
EMLA Patch empl 20 pce
Description (DE)
EMLA Patch Pfl 20 Stk
Market launch
14/11/1995
Narcotic (BTM)
No

Available generics

Other packaging sizes

EMLA Patch empl 2 pce
2 PFLA
View